Panome Bio

Panome Bio

Biotechnology Research

Saint Louis, MO 3,329 followers

Next-Generation Metabolomics, Lipidomics, & Proteomics

About us

Panome Bio can help you profile and discover biomarkers with our Next-Generation Metabolomics capabilities, comprehensive workflows and personalized data analysis reports. Our Next-Generation Metabolomics platform is making major advancements in the metabolism field by going beyond pairwise comparisons and making complex experiments with large and complicated datasets possible. Cutting-edge technology and computational methods are used to extract only the biologically-relevant chemical compounds to give you a clearer view of phenotype. We provide a global and unbiased view of the metabolome through a suite of complementary LC/MS assays that captures the breadth of diverse metabolites in biological systems. We have the ability to complement your metabolomics data with proteomics to better understand pathways and metabolism through our partnership with Somalogic. Somalogic’s SomaScan® 7K Assay is a high-throughput proteomics assay that screens 7,000 proteins per sample simultaneously.

Website
www.panomebio.com
Industry
Biotechnology Research
Company size
11-50 employees
Headquarters
Saint Louis, MO
Type
Privately Held
Founded
2022
Specialties
Metabolomics , Proteomics, Data Analysis, Bioinformatics, Biomarker Discovery, and Metabolism

Locations

Employees at Panome Bio

Updates

Similar pages

Funding

Panome Bio 1 total round

Last Round

Series A

US$ 6.0M

See more info on crunchbase